Statistics for Development of an antisense-mediated exon skipping approach as a therapeutic option for the ML II-causing mutation c.3503_3504delTC
Total visits
| views | |
|---|---|
| Development of an antisense-mediated exon skipping approach as a therapeutic option for the ML II-causing mutation c.3503_3504delTC | 29 |
Total visits per month
| views | |
|---|---|
| June 2025 | 1 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| ESGLD 2017 - Abstract SA - delTC therapy.pdf | 14 |
Top country views
| views | |
|---|---|
| United States | 10 |
| India | 6 |
| China | 5 |
| Portugal | 3 |
| Singapore | 2 |
| Canada | 1 |
| France | 1 |
| United Kingdom | 1 |
Top city views
| views | |
|---|---|
| Singapore | 1 |